Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Src/Bcr Abl

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Src/Bcr Abl

Chemical Structure Cat. No. Product Name CAS No.
TPX-0046 Chemical Structure
BCP43814 TPX-0046 TPX0046
TPX-0046 is a novel RET/SRC inhibitor with a mean IC50 of 17 nM for RETG810R in Ba/F3 cell proliferation assay.
Vodobatinib Chemical Structure
BCP43522 Vodobatinib 1388803-90-4
Vodobatinib, also known as K-0706, is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity.
CSF1R-IN-2 Chemical Structure
BCP40929 CSF1R-IN-2 2271119-26-5
TPX-0022, also known as CSF1R-IN-2, is an orally bioavailable multi-targeted kinase inhibitor with a novel three-dimensional macrocyclic structure that inhibits the MET, CSF1R (colony stimulating factor 1 receptor) and SRC kinases.
KX2-391 Mesylate Chemical Structure
BCP25173 KX2-391 Mesylate 1080645-95-9
Tirbanibulin, also known as KX-01 and KX2-391, is the first clinical Src inhibitor of the novel peptidomimetic class that targets the peptide substrate site of Src providing more specificity toward Src kinase.
TL02-59 Chemical Structure
BCP38228 TL02-59 1315330-17-6
TL02-59 is a novel potent and selective inhibitor of the myeloid Src-family kinase Fgr, suppressing AML cell growth in vitro and in vivo.
DGY-06-116 Chemical Structure
BCP37659 DGY-06-116 2556836-50-9
DGY-06-116 is an irreversible covalent, selective Src inhibitor.
PD173955-Analog1 Chemical Structure
BCP36116 PD173955-Analog1 185039-99-0
PD 173955-Analog1 is a potent c-Src inhibitor known to have activity against a variety of cancers including colon, lung, head and neck carcinoma.
CH6953755 Chemical Structure
BCP35548 CH6953755 2055918-71-1
CH6953755 is a potent, orally active and selective YES1 kinase (a member of the SRC family) inhibitor with an IC50 of 1.8 nM. CH6953755 inhibits YES1 kinase, leading to antitumor activity against YES1 Gene -amplified cancers in vitro and in vivo.
GMB-475 Chemical Structure
BCP31499 GMB-475 2490599-18-1
GMB-475 is a degrader of BCR-ABL1 tyrosine kinase based on PROTAC, overcoming BCR-ABL1-dependent drug resistance.
TG 100572 Hydrochloride Chemical Structure
BCP21364 TG 100572 Hydrochloride 867331-64-4
TG 100572 Hydrochloride is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 nM for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
123下一页末页共 83 条记录 1 / 9 页 
0086-13720134139